description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGCTGACTTGGAGAGCAGAACAAGAAGGTGGCATGCAATTCTGGGTGTCATCAGAGTCCAAACTTTCTGACTCCTGGCAGCCACGCTCCCTGGATATTGAAGTTGCAGCCTATGCACTGCTCTCACACTTCTTACAATTTCAGACTTCTGAGGGAATCCCAATTATGAGGTGGCTAAGCAGGCAAAGAAATAGCTTGGGTGGTTTTGCATCTACTCAGGATACCACTGTGGCTTTAAAGGCTCTGTCTGAATTTGCAGCCCTAATGAATACAGAAAGGACAAATATCCAAGTGACCGTGACGGGGCCTAGCTCACCAAGTCCTGTAAAGTTTCTGATTGACACACACAACCGCTTACTCCTTCAGACAGCAGAGCTTGCTGTGGTACAGCCAACGGCAGTTA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Guijuan Zong et al.
Digestive diseases and sciences, 61(8), 2303-2314 (2016-04-15)
Hepatocellular carcinoma (HCC) accounts for 75-80 % of primary liver cancer, and usually arises after years of liver disease. Thus it is important to understand the molecular mechanisms which drive or mediate the development of HCC. In this work, we examined
Xue-Tang Mo et al.
British journal of cancer, 123(5), 833-843 (2020-06-09)
CD109 was involved in the tumorigenesis and progression of various cancers via TGF-β1 signalling and STAT3 activation. As CD109 is strongly expressed in cervical squamous cell carcinoma, this study was conducted to investigate its functional characteristics in cervical cancer. CD109
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持